Hey rjs, well, then we actually are of opposite

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel rjs9787 #26754
410
Hey rjs,

well, then we actually are of opposite opinions.

You wrote that "And no one heard anything taking several more weeks..." and that this is only my own interpretation.

Hmmm, if I read the post from skipper, where he quotes a message from
Joe, that

Quote:
"The results were received. Now they need to be certified by COVANCE, Elispot, Univ. of San Diego, CTL, then a statistical analysis has to be performed.

Further reviews are then needed by:
Advisory board;
Head of FDA pediatrics;
NIH;
DOD (me I’m not sure about this one)"

With all that listed it is not far fetched to assume that this will at least take "a couple of more weeks", right?

Some additional points that I'd like to add:
1) Whatever Mr Purcell lectured about might have been interesting for you, as you were able to follow, but it was rather dull for me, as I only understand a fraction of it, both due to the terrible sound quality and the fact that I don't happen to be a biochemist, but a physicist. So to be honest, I personally wouldn't have needed that biochemistry lecture. It would have been sufficient for me to hear, that the tests were very successful and they are now being handed into the FDA as basis for the IND application to gain approval to start the clinical trials.
While I didn't need the first, and wanted the second, I received the first and was put off about the second. That is what I mean when I write that I see a disconnect in the communication between GNBT's management team and us, their shareholders.
I want to hear the success stories and reliable timelines on how things will continue to progress, and they - excuse me - bore me with biochemistry details.
2) Honestly, I have no problem with waiting another 6 weeks or so. I have learned to be patient, not just because I have already been a long time GNBT shareholder for a very long time, LOL. But I am asking, or even demanding an open an reliable communication between GNBT's management and myself, such that I can count on information and timelines given to me. If I would have been told during the CC, that in 10 days GNBT will receive lab test results, and then the chain of next steps need to be happening, and step 1 takes 3 days, step 2 takes 1 week, ... and it all will take 6 weeks total to accomplish and only then the IND application to the FDA can happen, and another 4 weeks later the clinical trials can start. I guess that would have been sufficient for me. Especially, if I woulld receive a first update 3 days later, telling me that step1 is complete. BECAUSE, in such a case, I can ask myself, is it worth it for me to stay invested for another 6 weeks, and am I willing to wait for such a long time. And I guess, if it would be reliably communicated to me, I would be willing to be patient and stay invested. But what I personally find catastrophic is the assumption Joe seems to constantly make is that I know what he means 6 weeks, when he says "in the coming days", or that we all know that once the results have been received that it requires all the additional steps, and I cannot expect to receive a PR immediately afterwards that gives me the executive summary, of "Thumbs up, test results are very positive, and now it will take about 6 more weeks, before we can start with the clinical trials". The way it is carried out by the GNBT management is what I would call "Salami tactic", ie. you deliver the full information slice after slice. That is terrible, to be honest.

3) I know that I repeat myself, but what I still don't really get is that I continue to have the impression that they seem to be absolutely in no rush. I understand, as docj has put it, that this is not baking bagels for Sunday's breakfast, but to stay in that metaphor no bakery is able to sell bagels for the Sunday breakfast on a Monday afternoon. If you catch my drift, what I mean to say by this is that of course everything needs to be carried out very thoroughly, but why am I left with the impression that with GNBT EVERYTHING always takes significantly longer than for the competition. Are they really aware that they are still in a race for the best vaccine? Is this just my fals impression here? I don't think so, and we might have the best ever vaccine, but when everybody has received a first vaccination and/or the virus has already significantly mutated, it will surely be too late even FOR THE BEST EVER "Complete Vaccine".

I know, I know, it is up to me to decide whether it is worth for me to stay invested or move on, but for such a decision I would need reliable timelines to think for myself whether this will still lead to a FDA approved CV-19 vaccine when there still would be a market for it, or not. Because, in the end, the best ever vaccine is only as good as it is useful and fast enough available for a mass market.

So let's really hope that you are right with your assumption that we will receive an update via PR early next week, otherwise I am sure that a lot of people are getting very impatient very soon. I am not talking about myself here in particular, but I have endless discussions on my German message board with a bunch of users, who already now talk about this being fraud. I am surely not one of them, but for sure I am frustrated.
As, I guess, most of us agree, this is "show me time" for GNBT, and yet another delay of showing us the facts is surely not going to help the PPS to increase, as we are all hoping for, right?

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Franklin Financial Q3: 59% Net Income Surge Amid Growth

Updated Category News Views 39

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 64

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading
Justin Boots Revamps Ada with Bold New Colors

Updated Category News Views 0

Reimagining a Western Favorite Howdy, folks! A staple in the Western wear scene just got a fresh paint job, and it's got people talking from Fort Worth to far beyond. The beloved Ada boot from Justin Boots is sashaying its way back in five fresh colorways that slap a modern twist on a vintage favorite. It's like trying to breathe some new life into an old rodeo star,...

Continue Reading
Advanced Process Solutions Reshuffles Leadership Amid Growth

Updated Category News Views 76

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

Continue Reading
Spotlight on Disability Inclusivity: 10 Honorees Celebrated

Updated Category News Views 39

Celebrating Champions of Inclusivity April 17, 2026 was a red-letter day for hope and progress in Garden Grove. The Regional Center of Orange County (RCOC) hosted its 29th annual Spotlight Awards, tipping their hats to ten trailblazing individuals and organizations. In a society where the marginalized often get left out of the success parade, these folks are ahead of the...

Continue Reading
Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 0

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Vertiv's $1.45B Bet on Transforming Power Solutions

Updated Category News Views 107

Power Play: Vertiv's Big Move Amid the chatter of acquisitions, Vertiv's hefty $1.45 billion swoop for UtilityInnovation Group isn’t just another line in the ledger. This one’s got substance. It's one of those moves where the dollars translate directly into future-proofing in a real sense—not just padding out some exec's CV. Filling the Gaps in AI Infrastructure...

Continue Reading
Big Names Gather for MAHA Rally in Iowa

Updated Category News Views 27

Wind of Change Blows Through Iowa It's campaign season, and Iowa is buzzing with the anticipation of the upcoming Make Iowa Healthy Again Rally set for Oct. 28. The MAHA PAC rally promises to be no small potatoes, capturing attention with its gathering of big names and a punchy aim to reenergize the political landscape in the heartland. Headliners and Influential Figures...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 0

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe

Updated Category News Views 114

Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....

Continue Reading

Top 5 Most Recently Viewed Articles

Essential Water Safety Skills for Kids This Swim Season

Updated Category News Views 225

Prepare Your Kids for Safe Swimming Experiences As the summer swim season approaches, ensuring children are equipped with essential water safety skills becomes paramount. The American Red Cross has made significant strides in this regard by revamping its educational program, Longfellow's WHALE Tales, now offered in Spanish. This initiative strives to reach children from...

Continue Reading
Revolutionizing Credential Security with Dashlane Omnix™

Updated Category News Views 387

Revolutionizing Credential Security with Dashlane Omnix™ - Dashlane is the first to unify proactive credential protection and password management in one platform to secure every user credential. - New Dashlane Omnix™ platform is generally available, accompanied by new capabilities that equip security teams to pinpoint and expedite response to credential threats. Today...

Continue Reading
Marex Group plc Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 208

Understanding the Lawsuit Against Marex Group plc Investors are currently presented with a significant opportunity regarding Marex Group plc, a company listed under the ticker MRX. This matter emerged in light of allegations tied to securities fraud, compelling claims that could impact many stakeholders. The Schall Law Firm, renowned for its involvement in shareholder...

Continue Reading
European Wellness and Jilin Hanxing Group Ignite a New Era

Updated Category News Views 191

A New Era for Wellness Begins with European Wellness and Jilin Hanxing Group KOTA KINABALU, Malaysia — A notable alliance is on the horizon that could change the landscape of global wellness and regenerative medicine. European Wellness Biomedical Group has joined forces with Jilin Hanxing Group, marking a crucial milestone in fostering international partnerships within...

Continue Reading
Qorvo Board Expansion: Peter Feld Nominated for Directors

Updated Category News Views 172

Qorvo Announces Board Expansion with Peter Feld Nomination Qorvo (NASDAQ: QRVO), a prominent player in the technology sector, has declared a significant change in its Board of Directors. The Board has unanimously resolved to increase its size from nine to ten directors, paving the way for the nomination of Peter Feld, the Managing Member of Starboard Value LP, to its...

Continue Reading